Add to ORKGof personalized medicine strategies in acute myeloid leukemia The cost-e ectiveness of personalized m edicine strategies in acute m yeloid leukem i
ABSTRACT We present an individualized systems medicine (ISM) approach to optimize cancer drug therap...
Acute leukemia (AL) represents a hematological cancer originated from malignantly transformed myeloi...
The development and design of immune-based strategies have become an increasingly important topic du...
markdownabstract__Abstract__ Cancer is one of the most important health problems in the developin...
Objective To summarize the risk stratification and current treatment strategies for acute myeloid le...
New therapetic approaches for AML were described with special emphasis on targeted therapies
The term personalized medicine has been employed in widely different contexts and has acquired statu...
Acute myeloid leukaemia (AML) is a malignant disorder of the myeloid blood lineage characterized by ...
Summary: Patient-specifi c ex vivo drug sensitivity and resistance screening can identify rational d...
International audienceThe confrontation of the macro- and micro-economic approaches of hospital cost...
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by impaired differentiation of...
Acute myeloid leukemia (AML) is a disease characterized by hematopoietic and progenitor stem cells d...
Acute myeloid leukemia is a heteroge-neous disease that accounts for approxi-mately 20 % of acute le...
ABSTRACT We present an individualized systems medicine (ISM) approach to optimize cancer drug therap...
Acute leukemia (AL) represents a hematological cancer originated from malignantly transformed myeloi...
The development and design of immune-based strategies have become an increasingly important topic du...
markdownabstract__Abstract__ Cancer is one of the most important health problems in the developin...
Objective To summarize the risk stratification and current treatment strategies for acute myeloid le...
New therapetic approaches for AML were described with special emphasis on targeted therapies
The term personalized medicine has been employed in widely different contexts and has acquired statu...
Acute myeloid leukaemia (AML) is a malignant disorder of the myeloid blood lineage characterized by ...
Summary: Patient-specifi c ex vivo drug sensitivity and resistance screening can identify rational d...
International audienceThe confrontation of the macro- and micro-economic approaches of hospital cost...
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by impaired differentiation of...
Acute myeloid leukemia (AML) is a disease characterized by hematopoietic and progenitor stem cells d...
Acute myeloid leukemia is a heteroge-neous disease that accounts for approxi-mately 20 % of acute le...
ABSTRACT We present an individualized systems medicine (ISM) approach to optimize cancer drug therap...
Acute leukemia (AL) represents a hematological cancer originated from malignantly transformed myeloi...
The development and design of immune-based strategies have become an increasingly important topic du...